Geoff Race - 04 Oct 2023 Form 4 Insider Report for Minerva Neurosciences, Inc. (NERV)

Role
President
Signature
/s/ Ryan Sansom, Attorney-in-Fact
Issuer symbol
NERV
Transactions as of
04 Oct 2023
Transactions value $
$0
Form type
4
Date filed
05 Oct 2023, 16:33
Previous filing
02 May 2023
Next filing
06 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NERV Employee Stock Option (right to buy) Award $0 +87.1K $0.00 87.1K 04 Oct 2023 Common Stock 87.1K $6.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on October 4, 2024 and then in equal quarterly installments over 3 years thereafter.